PALM BEACH, Florida, March 3, 2020 /PRNewswire/ -- Although there is presently no cure for glioblastoma, researchers are continually inching closer to new and effective treatment options. Glioblastoma is a type of brain cancer that affects the astrocytes, which are a type of cell found in the brain and spinal cord. This form of cancer can occur anywhere astrocytes are fo

AUSTIN, Texas, Mar. 3, 2020 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced that its Executive Vice President, Investor Relations, Scott Powell, is scheduled to present at five conferences in March 2020.During the conferences, Dr. Powell will outline Volition's busin

BEIJING, March 3, 2020 /PRNewswire/ -- China Biologic Products Holdings, Inc. (NASDAQ: CBPO) ("China Biologic" or the "Company"), a leading fully integrated plasma-based biopharmaceutical company in China, today announced that the Company plans to release its fourth quarter and fiscal year 2019 financial results on

SAN FRANCISCO, March 3, 2020 /PRNewswire/ --  Tivic Health® Systems Inc., today announced that ClearUP® Sinus Pain Relief, a small handheld device

STOCKHOLM, March 3, 2020 /PRNewswire/ -- RhoVac AB ("RhoVac") announces today, on 3rd March 2020, that the first patient in Finland has started treatment in the company's clinical phase IIb study in prostate cancer, a study entitled RhoVac-002 ("BRaVac").The first patient in Finland

WASHINGTON, March 3, 2020 /PRNewswire/ -- The American Red Cross has selected Melanie R. Sabelhaus of Naples, Florida; Baltimore, Maryland; and Nantucket, Massachusetts as the winner of the 2020 Harriman Award for Distinguished Volunteer Servi

SAN JUAN CAPISTRANO, Calif., March 3, 2020 /PRNewswire/ -- The Ellipsys® Vascular Access System enables patients with kidney failure to start dialysis treatment sooner with fewer procedures, complications and interventions compared to surgery, according to several leading physicians who spoke at the recent meeting of the American Society of Diagnostic and Interventional Nephr

SAN DIEGO, March 3, 2020 /PRNewswire/ -- Lipidio Pharmaceuticals, Inc. (Lipidio), a newly established biopharmaceutical company developing drugs to treat diseases associated with excess body fat, announced today the first close of its Series A financing to support the development of its lead therapeutic candidate GDD3898. Therapeutic areas of interest include nonalc

JACKSONVILLE, Fla., March 3, 2020 /PRNewswire/ -- Wounded Warrior Project® (WWP) and

SAN MATEO, Calif., March 3, 2020 /PRNewswire/ -- 19Labs, the leader in telehealth point-of-care solutions, announced today the availability of GALE|QKIT. Based on the GALE|MINI telehealth solution, the GALE|Q Kit enables governments and municipalities to implement minimally disruptive quarantine policies by enabling effective monitoring of potentially infected indiv